Immunoglobulin Product Market Intelligence Report - Global Forecast to 2027

Immunoglobulin Product Market Intelligence Report - Global Forecast to 2027

The Global Immunoglobulin Product Market is projected to reach USD 21,081.76 million by 2027 from USD 11,292.24 million in 2021, at a CAGR 10.96% during the forecast period.

Market Statistics:

The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered the forecast period.

• The Americas Immunoglobulin Product Market size was estimated at USD 4,039.23 million in 2021 and expected to reach USD 4,425.37 million in 2022, at a CAGR 10.51% to reach USD 7,357.27 million by 2027.
• The Asia-Pacific Immunoglobulin Product Market size was estimated at USD 3,277.57 million in 2021 and expected to reach USD 3,688.54 million in 2022, at a CAGR 11.56% to reach USD 6,319.45 million by 2027.
• The Europe, Middle East & Africa Immunoglobulin Product Market size was estimated at USD 3,975.43 million in 2021 and expected to reach USD 4,401.28 million in 2022, at a CAGR 10.92% to reach USD 7,405.03 million by 2027.

Market Segmentation & Coverage:

The report on immunoglobulin product identifies key attributes about the customer to define the potential market and identify different needs across the industry. Understanding the potential customer group's economies and geographies can help gain business acumen for better strategic decision-making. Our market coverage across different industry verticals reveals the hidden truth about the players' strategies in different verticals and helps the organization decide target audience. This report gives you the composite view of sub-markets coupled with comprehensive industry coverage and provides you with the right way of accounting factors such as norms & regulations, culture, to make right coverage strategy for your market plan.

This research report categorizes the immunoglobulin product to forecast the revenues and analyze the trends in each of the following sub-markets:

Type:

• IGA
• IGD
• IGE
• IGG
• IGM

ROA:

• IMIG
• IVIG
• SCIG

Application:

• CIDP
• CLL
• Congenital AIDS
• Hypogammaglobulinemia
• ITP
• Immunodeficiency Diseases
• Kawasaki Disease
• Multifocal Motor Neuropathy
• Myasthenia Gravis

Region:

• Americas
  • Argentina
  • Brazil
  • Canada
  • Mexico
  • United States
    • California
    • Florida
    • Illinois
    • New York
    • Ohio
    • Pennsylvania
    • Texas
• Asia-Pacific
  • Australia
  • China
  • India
  • Indonesia
  • Japan
  • Malaysia
  • Philippines
  • Singapore
  • South Korea
  • Taiwan
  • Thailand
• Europe, Middle East & Africa
  • France
  • Germany
  • Italy
  • Netherlands
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • United Arab Emirates
  • United Kingdom

Company Usability Profiles:

• Baxter International Inc.
• Bayer AG
• Beckman Coulter Inc.
• Bio Products Laboratory Ltd.
• Biotest AG
• China Biologic Products Holdings, Inc.
• CSL Limited
• Emergent BioSolutions Inc.
• Evolve Biologics Inc.
• F. Hoffmann-La Roche AG
• GigaGen, Inc.
• Immunos Therapeutics
• Kamada Ltd.
• Kedrion Biopharma
• LFB group
• Octapharma AG
• Sanquin Plasma Products B.V.
• Takeda Pharmaceutical Company Limited

Currency: USD

Base Year: 2021

Estimated Year: 2022

Forecast Year: 2027

Base Year Value: USD 11,292.24 million

Estimated Year Value: USD 12,515.19 million

Forecast Year Value: USD 21,081.76 million

CAGR (%): 10.96%.

Please Note: PDF & Excel + Online Access - 1 Year